Results 201 to 210 of about 170,525 (342)

Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis [PDF]

Haressh Sajiir, Sahar Keshvari, Kuan Yau Wong, Danielle J. Borg, Frederik J. Steyn, Christian Fercher, Karin Taylor, Breten Taylor, Ross Barnard, Alexandra Müller, Md. Moniruzzaman, Gregory M. Miller, Ran Wang, Amelia K. Fotheringham, Veronika Schreiber, Yonghua Sheng, Janelle Louise Hancock, Dorothy Loo, Lucy Burr, Tony Huynh, Jack Lockett, Grant A. Ramm, Graeme A. Macdonald, Johannes B. Prins, Michael A. McGuckin, Sumaira Z. Hasnain   +25 more
openalex   +1 more source

Time to Include Nonalcoholic Steatohepatitis in the Management of Patients With Type 2 Diabetes [PDF]

, 2020
Kenneth Cusi
openalex   +1 more source

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis [PDF]

, 2021
Hyeong Geug Kim, Jung-Hyo Cho, Jeongkyu Kim, Seung-Jin Kim   +3 more
openalex   +1 more source

Pharmacological effects of gastrodin: Insight into neurological diseases and mechanism in ferroptosis and pyroptosis

Ibrain, Volume 11, Issue 1, Page 74-83, Spring 2025.
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley   +1 more source

Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management

, 2019
Soo Ki Kim, Ke Ih Kim, Soo Ryang Kim
openalex   +2 more sources

Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis [PDF]

, 2007
Kanji Yamaguchi, Liu Yang, Shannon J. McCall, Jiawen Huang, Xing Yu, Sanjay K. Pandey, Sanjay Bhanot, Brett P. Monia, Yin-xiong Li, Anna Mae Diehl   +9 more
openalex   +1 more source

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Alimentary Pharmacology and Therapeutics, 2011
G. Vernon, G. Vernon, A. Baranova, A. Baranova, Z. Younossi, Z. Younossi   +5 more
semanticscholar   +1 more source

Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.

Journal of Hepatology, 2022
Qi Wang, Haoming Zhou, Qingfa Bu, Song Wei, Lei Li, Jinren Zhou, Shun Zhou, Wantong Su, Mu Liu, Zheng Liu, Mingming Wang, Ling Lu   +11 more
semanticscholar   +1 more source

Genetic variants underlying precancerous conditions of hepatocellular carcinoma

International Journal of Cancer, EarlyView.
Abstract Hepatocellular carcinoma (HCC) is the most common form of liver cancer, accounting for 80% of cases worldwide. While chronic hepatitis B and C infections remain primary risk factors, emerging evidence highlights the increasing contributions of metabolic dysfunction‐associated steatotic liver disease (MASLD) and alcohol‐associated liver disease
Jonathan Jaime G. Guerrero, Paolo C. Encarnacion, Mark Angelo S. del Rosario, Matthew Aldren S. Ora, Jiayan Zhou, Kin Israel Notarte, Wan‐Chun Li, Ching‐Wen Chang   +7 more
wiley   +1 more source

Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.

Clinical Gastroenterology and Hepatology, 2020
Z. Younossi, M. Stepanova, J. Ong, G. Trimble, S. Alqahtani, I. Younossi, Aijaz Ahmed, A. Racila, L. Henry   +8 more
semanticscholar   +1 more source